Skip to content

Clinical trials

Disorders of Excessive Somnolence trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20071
20081
20161
20191
20201
20214
20232
20242
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axsome Therapeutics, Inc.4
Alkermes, Inc.3
Cephalon3
Harmony Biosciences Management, Inc.3
Avadel2
Centessa Pharmaceuticals (UK) Limited1
Cerebra Medical1
Jazz Pharmaceuticals1
Laval University1
Orphan Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence23
Narcolepsy11
Cataplexy7
Sleep Wake Disorders4
Idiopathic Hypersomnia3
Sleep Apnea, Obstructive3
Fatigue2
Myotonic Dystrophy2
Major Depressive Disorder1
Parasomnias1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.